Diagnostic and therapeutic technology assessment. Alpha-interferon and chronic myelogenous leukemia.
D000574:American Medical Association; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000628:therapy; D015466:Leukemia, Myeloid, Chronic-Phase / Q000628:therapy*; D011994:Recombinant Proteins; D013673:Technology Assessment, Biomedical; D014481:United States
D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins